« Return to News | CROs/Service Providers

ACRO launches educational YouTube channel

Thursday, March 22, 2012 02:49 PM

In an effort to educate the public, media and policymakers about clinical trials and the growing role of CROs in the drug development process, the Association of Clinical Research Organizations (ACRO) has launched a YouTube channel @ACROHealthChannel.

"Increasingly, the ACRO member companies constitute the global drug development infrastructure," said John Lewis, ACRO’s vice president of public affairs. "With a footprint now in 115 countries and responsibility for annually conducting more than 11,000 clinical trials involving two million participants, we have an obligation to engage and educate our various constituencies about issues effecting clinical research. These topics range from ensuring human subject protections to cultivating favorable regulatory and economic environments that promote more efficient drug development."

The first two videos on ACROHealthChannel feature 2012 ACRO Chairman Jeff McMullen, president and CEO of PharmaNet/i3, discussing the association's agenda for the year, and Neil McCollough, vice president of global quality and compliance at PPD, discussing issues in bioethics and the globalization of research.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.